Prospective Clinical Assessment Study in Children With Hypochondroplasia

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Hypochondroplasia
Trial Locations (25)

3052

RECRUITING

Murdoch Children's Research Institute, Parkville

5021

RECRUITING

Haukeland University Hospital, Bergen

17164

RECRUITING

Astrid Lindgren Children's Hospital, Solna

20010

RECRUITING

Children's National Hospital, Washington D.C.

21287

RECRUITING

Johns Hopkins School of Medicine, Baltimore

31059

RECRUITING

Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants, Toulouse

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

53705

RECRUITING

University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic, Madison

65201

RECRUITING

University of Missouri, Columbia

69677

RECRUITING

Hôpital Femme Mère Enfant HCL, Bron

75015

RECRUITING

Hôpital Necker-Enfants Malades, Paris

80045

RECRUITING

Childrens Hospital Colorado, Aurora

94609

RECRUITING

UCSF Benioff Children's Hospital, Oakland

229899

RECRUITING

KK Women's and Children's Hospital, Singapore

N6C 2R5

RECRUITING

London Health Sciences Centre - Children's Hospital of Western Ontario, London

K1H 8L1

RECRUITING

Children's Hospital of Eastern Ontario Research Institute, Ottawa

H3T 1C5

RECRUITING

Université de Montréal - Centre Hospitalier Universitaire Sainte-Justine, Montreal

0372

RECRUITING

Paediatric Clinical Research Unit at Oslo University Hospital, Oslo

3000-602

RECRUITING

Hospital Pediátrico de Coimbra, Coimbra

01008

RECRUITING

Hospital Vithas San Jose, Vitoria-Gasteiz

W1W 5AH

RECRUITING

The Portland Hospital for Women and Children, London

M13 9WL

RECRUITING

Manchester University, Manchester

S10 2TH

RECRUITING

Sheffield Children's NHS Foundation Trust, Sheffield

G51 4TF

RECRUITING

Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow

All Listed Sponsors
lead

QED Therapeutics, Inc., a Bridgebio company

INDUSTRY